Efficacy of JINLINGGUAN and TOFER Formula in Formula-fed Chinese Term Infants
NCT03178474 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2017-09-18
Summary
Objective:The present trial aimed to assess efficacy and safety of Jin Ling Guan and Tofer infant formula on body growth, intestinal tolerance, gut microbiota and fecal residual nutrients as compared to breast-milk in term Chinese infants.
Participants:189 healthy termed-infants with ages of 5-14 days at the enrollment.
Study Design: A multiple-center, quasi-randomized,open labeled, controlled trial. Random allocation between the two infant formula.
Arms, Groups, and Intervention: (1) Breast milk-fed group: fed with human breast milk; (2) JINLINGGUAN Formula Group:fed with JINLINGGUAN infant formula (PRO-KIDO™ I-PROTECH®, Phase I); (3) TOFER Formula Group: feeding TOFER infant formula (TOFER®, Phase I). Random allocation performed between the two formula groups.
Intervention Duration: 12 weeks.
Visits: 1 week(baseline), 7 and 13 weeks of age
Outcome measures: (1) General information, general health and wellbeing, regular body check;(2) Anthropometric parameters: body length, body weight, and head circumferences; (3) Stool characteristics (color , volume, stool consistency, and frequency;(4)Behavior and habits; (5) Gut microbiota; (6) Residual nutrients in feces (nitrogen,total fat, fatty acids, minerals); (7) adverse events and concomitant medications; (8) compliance. Slopes of changes from baseline to 6 and 12 weeks post intervention in anthropometric parameters, stool characteristic index, fecal residual nutrients, pattern score of gut microbiota, behavior and habit index were be calculated.
Conditions
- Infant Formula Intolerance
- Well-being
Interventions
- OTHER
-
JINLINGGUAN Infant formula,PRO-KIDO™ I-PROTECH®
JINLINGGUAN Infant formula,PRO-KIDO™ I-PROTECH®: a type of Phase I infant formula for 0-6 month infants, with a trademark of PRO-KIDO™ I-PROTECH®. The formula contains both OPO structured lipid and α+β patented protein (patent number: ZL200810241156.3).It was produced by Inner Mongolia Yili Industrial Group Co.Ltd.,China
- OTHER
-
TOFER Infant formula,TOFER®
TOFER Infant formula,TOFER®: a type of Phase I infant formula for 0-6 month infants, with a trademark of TOFER®. The formula was characterized by (1) Moderate digestible small-molecule protein; and (2) BID® complex probiotics. It was produced by Inner Mongolia Yili Industrial Group Co.Ltd.,China
- OTHER
-
Breast milk
Breast milk: Human breast milk, provided and fed by the corresponding infant's mother
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Yuming Chen, Ph.D. · Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Days
- Max Age
- 14 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-12-01
- Primary Completion
- 2017-06-30
- Completion
- 2017-12-30
Countries
- China
Study Locations
More Related Trials
-
Protocol for Feeding Intolerance in Preterm Infants
NCT05347706 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Two HMOs in Chinese Infants
NCT06361719 ·Status: RECRUITING ·Phase: NA
-
Tolerance and Efficacy of Wondersun Infant Formula in Formula-fed Chinese Term Infants
NCT01157390 ·Status: COMPLETED ·Phase: PHASE4
-
Parental Notions and Clinical Experiences About Child's Gut Comfort, Overall Satisfaction and Sense of Well-being When Consuming a New Toddler Milk
NCT04768933 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217 ·Status: COMPLETED ·Phase: NA
-
Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China
NCT01373541 ·Status: COMPLETED ·Phase: NA
-
The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants
NCT04508257 ·Status: UNKNOWN ·Phase: NA
-
The Trial of a New Infant Formula in Healthy Term Chinese Infants
NCT06053112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas #3
NCT00977964 ·Status: COMPLETED ·Phase: PHASE3
-
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
NCT01137877 ·Status: TERMINATED ·Phase: PHASE3
-
Tolerance of Healthy Term Infants Fed Infant Formulas #4
NCT01155414 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effects of a Formula on the Gut Health of Healthy Chinese Infants and Young Children
NCT04864665 ·Status: COMPLETED ·Phase: NA
-
Effects of an Infant Formula on Growth, Safety and Efficacy for Healthy Term Infants
NCT04749290 ·Status: COMPLETED ·Phase: NA
-
An Exploratory RWE Study Exploring Effects of a Goat Milk Based Young Child Formula on Health Benefits
NCT06287385 ·Status: COMPLETED ·Phase: NA
-
The Effect of Feeding Infant Formula With Enriched Protein Fractions
NCT02274883 ·Status: COMPLETED ·Phase: NA
-
The Impact of a Prebiotics and Lactoferrin Containing Infant Formula on Stool Characteristics in Healthy Term Infants
NCT02363582 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562 ·Status: COMPLETED ·Phase: PHASE2
-
Feeding Tolerance and Gut Maturation of Infants Consuming a Formula Rich in Glycoprotein
NCT04880083 ·Status: COMPLETED ·Phase: NA
-
Growth and Tolerance of Young Infants
NCT03276884 ·Status: COMPLETED ·Phase: NA
-
Sensory Motor Interventions on Preterm Infants
NCT06263127 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort
NCT04733937 ·Status: COMPLETED ·Phase: NA
-
Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants
NCT02587702 ·Status: UNKNOWN ·Phase: NA
-
Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum
NCT05481866 ·Status: UNKNOWN ·Phase: NA
-
Growth and Tolerance of Young Infants Fed Infant Formulas
NCT01380886 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Unsettled Infants Experiencing Feeding Intolerance
NCT02021058 ·Status: COMPLETED ·Phase: NA